Pure Global
NCT06366373

An Evaluation on a Mental Health Art Exhibition's Impact on Reducing Stigma

An Evaluation on a Mental Health Art Exhibition's Impact on Reducing Stigma: a Real-world Quasi-experimental Study
Hunan University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mental Health Issue
Drug/Device/Intervention
A mental health art exhibition
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Hunan University
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Feb 01, 2025
Enrollment
1200 participants
Primary outcome

Stigma/discrimination regarding mental disorders

Summary

Mental health art exhibitions, as an intervention strategy integrating artistic expression
 and social contact, have the potential to positively impact the elimination of stigma and
 discrimination associated with mental health problems. This study will utilize a real-world
 quasi-randomized controlled trial design and a 6-month follow-up questionnaire survey to
 evaluate the intervention's impact on stigma/discrimination and related outcomes, such as
 mental health literacy. The evaluation will encompass four categories of people: those with
 lived experience of mental disorders, family members and friends of those with lived
 experience, health professionals, and the general public. Additionally, the
 cost-effectiveness of the art exhibition intervention will be analyzed.

ICD-10 classifications
Mental disorder, not otherwise specifiedMental and behavioural disordersUnspecified mental disorderProblems related to certain psychosocial circumstancesProblems related to other psychosocial circumstances
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06366373
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06366373 through Pure Global AI's free database. This phase not specified trial is sponsored by Hunan University and is currently Not yet recruiting. The study focuses on Mental Health Issue. Target enrollment is 1200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.